Clinical Trial Update: Study of XL999 in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of XL999 for metastatic colorectal cancer has been terminated. The document notes the study status as terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• XL999

Snippet

Sponsor: Symphony Evolution, Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED